This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chemi S.p.a.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Maria Lattanzio: Innovator in Polypeptide Analysis
Introduction
Maria Lattanzio is a prominent inventor based in Cinisello Balsamo, Italy. She has made significant contributions to the field of high-performance liquid chromatography (HPLC), particularly in the analysis of complex polypeptide mixtures. Her work is essential for the pharmaceutical industry, where precision and accuracy in drug formulation are critical.
Latest Patents
Maria holds a patent for her invention titled "RP-HPLC analysis of complex polypeptide mixtures." This innovative method focuses on reversed phase high-performance liquid chromatography techniques that are useful for characterizing glatiramer acetate and similar polypeptide mixtures. The method she developed can effectively distinguish glatiramer acetate from non-conforming copolymers, ensuring that only suitable batches are selected for pharmaceutical use. She has 1 patent to her name.
Career Highlights
Throughout her career, Maria has demonstrated a commitment to advancing analytical techniques in the pharmaceutical sector. Her expertise in HPLC has positioned her as a valuable asset in her field. She works at Chemi S.p.a., where she continues to innovate and contribute to the development of effective pharmaceutical solutions.
Collaborations
Maria collaborates with notable colleagues, including Aureliano Gaiassi and Andrea Stevenazzi. Their combined expertise enhances the research and development efforts at Chemi S.p.a., fostering an environment of innovation and excellence.
Conclusion
Maria Lattanzio is a trailblazer in the field of polypeptide analysis, with her patented methods paving the way for advancements in pharmaceutical applications. Her contributions are vital for ensuring the quality and efficacy of essential medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile